Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Атмосфера. Новости кардиологии
2021 / N 2

Лекарственно-индуцированная фибрилляция предсердий, ассоциированная с приемом лекарственных средств для лечения заболеваний бронхолегочной системы
О.Д. Остроумова, М.С. Черняева, Л.К. Данилова, И.Ф. Кроткова, Е.Е. Павлеева, Д.А. Сычев

References

1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman J, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal 2021 Feb;42(5):373-498.
2. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling F, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology, Prevention Statistics Committee, and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics – 2019 update: a report from the American Heart Association. Circulation 2019 May;139(10):e56-528.
3. Allan V, Honarbakhsh S, Casas JP, Wallace J, Hunter R, Schilling R, Perel P, Morley K, Banerjee A, Hemingway H. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants. Thrombosis and Haemostasis 2017 May;117(5):837-50.
4. Feghaly J, Zakka P, London B, MacRae CA, Refaat MM. Genetics of atrial fibrillation. Journal of the American Heart Association 2018 Oct;7(20):e009884.
5. van der Hooft CS, Heeringa J, van Herpen G, Kors JA, Kingma JH, Stricker BH. Drug-induced atrial fibrillation. Journal of the American College of Cardiology 2004 Dec;44(11):2117-24.
6. Kaakeh Y, Overholser BR, Lopshire JC, Tisdale JE. Drug-induced atrial fibrillation. Drugs 2012 Aug;72(12):1617-30.
7. Tamargo J, Caballero R, Delpón E. Drug-induced atrial fibrillation. Expert Opinion on Drug Safety 2012 Jul;11(4):615-34.
8. Tisdale JE, Miller DA. Drug-induced diseases: prevention, detection, and management. 3rd ed. Bethesda, Md.: American Society of Health-System Pharmacists; 2018. 1400 p.
9. Ostroumova OD, Chernyaeva MS, Komarova AG, Gorbatenkova SV, Sychev DA. Drug-induced atrial fibrillation associated with admission of cardiovascular medications. Siberian Medical Review 2020;(6):5-13 (In Russian).
10. Ostroumova OD, Chernyaeva MS, Kochetkov AI, Bakhteeva DI, Ivanov SN, Sychev DA. Atrial fibrillation associated with anticancer drugs. Safety and Risk of Pharmacotherapy 2020;8(4):178-90 (In Russian).
11. Desai R, Patel U, Singh S, Bhuva R, Fong HK, Nunna P, Zalavadia D, Dave H, Savani S, Doshi R. The burden and impact of arrhythmia in chronic obstructive pulmonary disease: insights from the National Inpatient Sample. International Journal of Cardiology 2019 Apr;281:49-55.
12. Vidal’s handbook: medicines in Russia, 2020. Tolmacheva EA, editor. Moscow: Vidal Rus; 2020. 1120 p. (In Russian).
13. Chazan R, Karwat K, Tyminska K, Tadeusiak W, Droszcz W. Cardiac arrhythmias as a result of intravenous infusions of theophylline in patients with airway obstruction. International Journal of Clinical Pharmacology and Therapeutics 1995 Mar;33(3):170-5.
14. Henderson A, Wright DM, Pond SM. Management of theophylline overdose patients in the intensive care unit. Anaesthesia and Intensive Care 1992 Feb;20(1):56-62.
15. Okada S, Teramoto S, Matsuoka R. Recovery from theophylline toxicity by continuous hemodialysis with filtration. Annals of Internal Medicine 2000 Dec;133(11):922.
16. Raoof S, Wollschlager C, Khan FA. Ciprofloxacin increases serum levels of theophylline. The American Journal of Medicine 1987 Apr;82(4A):115-8.
17. Holden R. Probable fatal interaction between ciprofloxacin and theophylline. BMJ 1988 Nov;297(6659):1339.
18. Richardson JP. Theophylline toxicity associated with the administration of ciprofloxacin in a nursing home patient. Journal of the American Geriatrics Society 1990 Mar;38(3):236-8.
19. Masoni A, Alboni P, Malacarne C, Codeca L. Effects of dobutamine on electrophysiological properties of the specialized conduction system in man. Journal of Electrocardiology 1979 Oct;12(4):361-70.
20. Lin CI, Chuang IN, Cheng KK, Chiang BN. Arrhythmogenic effects of theophylline in human atrial tissue. International Journal of Cardiology 1987 Dec;17(3):289-97.
21. Poukkula A, Korhonen UR, Huikuri H, Linnaluoto V. Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. Journal of Internal Medicine 1989 Oct;226(4):229-34.
22. Patel AK, Skatrud JB, Thomsen JH. Cardiac arrhythmias due to oral aminophylline in patients with chronic obstructive pulmonary disease. Chest 1981 Dec;80(6):661-5.
23. Varriale P, Ramaprasad S. Aminophylline-induced atrial fibrillation. Pacing and Clinical Electrophysiology 1993 Oct;16(10):1953-5.
24. O’Driscoll BR. Supraventricular tachycardia caused by nebulized ipratropium bromide. Thorax 1989 Apr;44(4):312.
25. Parr MK, Koehler K, Geyer H, Guddat S, Schänzer W. Clenbuterol marketed as dietary supplement. Biomedical Chromatography. BMC 2008 Mar;22(3):298-300.
26. Prather I, Brown D, North P, Wilson JR. Clenbuterol: a substitute for anabolic steroids? Medicine and Science in Sports and Exercise 1995 Aug;27(8):1118-21.
27. Choo J, Horan M, Little R, Rothwell NJ. Anabolic effects of clenbuterol on skeletal muscle are mediated by ß2-adrenoreceptor activation. The American Journal of Physiology 1992 Jul;263(1 Pt 1):E50-6.
28. Spann C, Winter ME. Effect of clenbuterol on athletic performance. The Annals of Pharmacotherapy 1995 Jan;29(1):75-7.
29. Daubert GP, Mabasa VH, Leung VW, Aaron C. Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation. Journal of Medical Toxicology 2007 Jun;3(2):56-60.
30. Patanè S, Marte F, La Rosa FC, La Rocca R. Atrial fibrillation associated with chocolate intake abuse and chronic salbutamol inhalation abuse. International Journal of Cardiology 2010 Nov;145(2):e74-6.
31. Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS. Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. Journal of Internal Medicine 1998 May;243(5):361-6.
32. Jartti TT, Kaila TJ, Tahvanainen KU, Kuusela TA, Vanto TT, Välimäki IA. Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children. European Journal of Pediatrics 1997 Nov;156(11):883-8.
33. Kochiadakis GE, Hamilos MI, Skalidis EI, Igoumenidis NE, Schiza SE, Vardas PE. Effect of inhaled salbutamol on coronary circulation in humans. International Journal of Cardiology 2007 May;117(3):408-10.
34. Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H, Zimetbaum PJ, Morganroth J. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine 2008 Nov;87(6):319-28.
35. Michele J, Stephan FL, Wentworth C 3rd, May C, Kesten S. Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database. Drug Safety 2007;30(12):1151-60.
36. VIDAL. Handbook of medicines. Available from: https://www.vidal.ru/drugs/molecule/1683 Accessed 2021 Dec 09 (In Russian).
37. State register of medicines. Available from: https://grls.rosminzdrav.ru/grls.aspx?s=%D0%9F%D1%81%D0%B5%D0%B2%D0%B4%D0%BE%D1%8D%D1%84%D0%B5%D0%B4%D1%80%D0%B8%D0%BD&m=mnn Accessed 2021 Dec 09 (In Russian).
38. MacMahon JR. Letter: atrial fibrillation and sympathomimetics. The Journal of Pediatrics 1974 Apr;84(4):613.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]